James S Scibetta - Net Worth and Insider Trading
James S Scibetta Net Worth
The estimated net worth of James S Scibetta is at least $565,025 dollars as of 2024-09-20. James S Scibetta is the President of Pacira BioSciences Inc and owns about 25,118 shares of Pacira BioSciences Inc (PCRX) stock worth over $368,983. James S Scibetta is the Director of Aquestive Therapeutics Inc and owns about 31,635 shares of Aquestive Therapeutics Inc (AQST) stock worth over $164,502. James S Scibetta is also the Director of Matinas BioPharma Holdings Inc and owns about 8,366 shares of Matinas BioPharma Holdings Inc (MTNB) stock worth over $31,540. Details can be seen in James S Scibetta's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James S Scibetta has not made any transactions after 2019-08-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James S Scibetta
James S Scibetta Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James S Scibetta owns 4 companies in total, including Matinas BioPharma Holdings Inc (MTNB) , Aquestive Therapeutics Inc (AQST) , and Pacira BioSciences Inc (PCRX) among others .
Click here to see the complete history of James S Scibetta’s form 4 insider trades.
Insider Ownership Summary of James S Scibetta
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MTNB | Matinas BioPharma Holdings Inc | 2017-09-07 | director |
AQST | Aquestive Therapeutics Inc | 2019-08-21 | director |
PCRX | Pacira BioSciences Inc | 2017-06-05 | Chief Financial Officer |
2007-11-16 | director |
James S Scibetta Latest Holdings Summary
James S Scibetta currently owns a total of 3 stocks. Among these stocks, James S Scibetta owns 25,118 shares of Pacira BioSciences Inc (PCRX) as of June 5, 2017, with a value of $368,983 and a weighting of 65.3%. James S Scibetta owns 31,635 shares of Aquestive Therapeutics Inc (AQST) as of August 21, 2019, with a value of $164,502 and a weighting of 29.11%. James S Scibetta also owns 8,366 shares of Matinas BioPharma Holdings Inc (MTNB) as of September 7, 2017, with a value of $31,540 and a weighting of 5.58%.
Latest Holdings of James S Scibetta
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PCRX | Pacira BioSciences Inc | 2017-06-05 | 25,118 | 14.69 | 368,983 |
AQST | Aquestive Therapeutics Inc | 2019-08-21 | 31,635 | 5.20 | 164,502 |
MTNB | Matinas BioPharma Holdings Inc | 2017-09-07 | 8,366 | 3.77 | 31,540 |
Holding Weightings of James S Scibetta
James S Scibetta Form 4 Trading Tracker
According to the SEC Form 4 filings, James S Scibetta has made a total of 0 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years. The most-recent trade in Pacira BioSciences Inc is the sale of 1,966 shares on June 5, 2017, which brought James S Scibetta around $85,167.
According to the SEC Form 4 filings, James S Scibetta has made a total of 0 transactions in Aquestive Therapeutics Inc (AQST) over the past 5 years. The most-recent trade in Aquestive Therapeutics Inc is the acquisition of 22,971 shares on August 21, 2019, which cost James S Scibetta around $87,060.
According to the SEC Form 4 filings, James S Scibetta has made a total of 0 transactions in Matinas BioPharma Holdings Inc (MTNB) over the past 5 years. The most-recent trade in Matinas BioPharma Holdings Inc is the acquisition of 100 shares on September 7, 2017, which cost James S Scibetta around $6,450.
Insider Trading History of James S Scibetta
- 1
James S Scibetta Trading Performance
GuruFocus tracks the stock performance after each of James S Scibetta's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James S Scibetta is 25.57%. GuruFocus also compares James S Scibetta's trading performance to market benchmark return within the same time period. The performance of stocks bought by James S Scibetta within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James S Scibetta's insider trading performs compared to the benchmark.
Performance of James S Scibetta
James S Scibetta Ownership Network
James S Scibetta Owned Company Details
What does Matinas BioPharma Holdings Inc do?
Who are the key executives at Matinas BioPharma Holdings Inc?
James S Scibetta is the director of Matinas BioPharma Holdings Inc. Other key executives at Matinas BioPharma Holdings Inc include Chief Business Officer Thomas Hoover , director & Chief Executive Officer Jerome D Jabbour , and Chief Financial Officer Keith A Kucinski .
Matinas BioPharma Holdings Inc (MTNB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Matinas BioPharma Holdings Inc (MTNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Matinas BioPharma Holdings Inc (MTNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Matinas BioPharma Holdings Inc (MTNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Matinas BioPharma Holdings Inc Insider Transactions
James S Scibetta Mailing Address
Above is the net worth, insider trading, and ownership report for James S Scibetta. You might contact James S Scibetta via mailing address: C/o Bioenvision, Inc., 345 Park Avenue, 41st. Floor, New York Ny 10154.